C vs CPHI
Citigroup Inc. (C) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
C currently screens at market cap $214.73B and trailing P/E 15.5. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the C and CPHI stock pages for the full models.
Not investment advice.